Minneapolis, MN, United States of America

Thomas Vasicek

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Vasicek: Innovator in Pharmaceutical Formulations

Introduction

Thomas Vasicek is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that address metabolic diseases. His innovative work has the potential to impact the treatment of various health conditions.

Latest Patents

Vasicek holds a patent for "Peptide YY pharmaceutical formulations, compositions, and methods." This patent includes pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, and metabolic hormones. The methods outlined in the patent focus on treating metabolic diseases using these compositions. Notably, the aspects of the patent include methods for increasing a feeling of fullness in patients treated with these pharmaceutical compositions.

Career Highlights

Vasicek is currently associated with Gila Therapeutics, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Throughout his career, Vasicek has collaborated with talented professionals, including Andres Acosta and Beth Anne-Szkudlarek Brown. These collaborations have contributed to the success of his projects and the advancement of their shared goals in the pharmaceutical industry.

Conclusion

Thomas Vasicek is a distinguished inventor whose work in peptide formulations is paving the way for new treatments in metabolic health. His contributions to the field exemplify the importance of innovation in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…